<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">163</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0188</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Sequence analysis of <italic>MYOC</italic> and <italic>CYP1B1</italic> in a Chinese pedigree of juvenile glaucoma with goniodysgenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xiaoming</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Naihong</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yun</surname><given-names>Hongmin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Jingjing</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Man</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Jiumo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Guiqun</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Hongbo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Mao</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Xuyang</given-names></name></contrib><aff id="aff1">Ophthalmic Laboratories and Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, P. R. China</aff></contrib-group><author-notes><fn><p>The first four authors contributed equally to this work.</p></fn><corresp id="cor1">Correspondence to: Dr. Xuyang Liu, Ophthalmic Laboratories and Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China; Phone/FAX: (86) 28-85164067; email: <email xlink:href="xliu1213@yahoo.com.cn">xliu1213@yahoo.com.cn</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>07</day><month>8</month><year>2009</year></pub-date><volume>15</volume><fpage>1530</fpage><lpage>1536</lpage><history><date date-type="received"><day>24</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>04</day><month>8</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>This study was designed to analyze two candidate genes, myocilin (<italic>MYOC</italic>) and cytochrome P450 1B1 (<italic>CYP1B1</italic>), in a Chinese pedigree of juvenile glaucoma with goniodysgenesis.</p></sec><sec><title>Methods</title><p>In a three-generation family of juvenile glaucoma with goniodysgenesis (13 members), six of them were patients with glaucoma and the rest were asymptomatic. All members of the family underwent complete ophthalmologic examinations. Exons of <italic>MYOC</italic> and <italic>CYP1B1</italic> were amplified by polymerase chain reaction, sequenced, and compared with a reference database.</p></sec><sec><title>Results</title><p>Elevated intraocular pressure (IOP) and visual function impairment was found in all patients, and goniodysgenesis was noticed in five of them (nine eyes) with relatively transparent corneas. One <italic>MYOC</italic> heterozygous mutation, c.1109 C&#x0003e;T (P370L), in exon 3 was identified in all six patients but not in the asymptomatic family members. Two <italic>CYP1B1</italic> single nucleotide polymorphisms (SNPs), g.3947 C&#x0003e;G (R48G) in exon 2 and 372&#x02212;12 C&#x0003e;T in intron 1, were identified in all six patients and but not in the asymptomatic family members except the proband&#x02019;s grandmother. Three SNPs were identified, 730 + 35 A&#x0003e;G in intron 2 of <italic>MYOC</italic> and g.8131 G&#x0003e;C (V432L) and g.8184 T&#x0003e;C (D449D) in exon 3 of <italic>CYP1B1</italic>.</p></sec><sec><title>Conclusions</title><p>The presence of a P370L mutation of <italic>MYOC</italic> in all six glaucoma patients suggests a casual association between this mutation and juvenile glaucoma with goniodysgenesis. The possible role of SNPs of <italic>CYP1B1</italic> in the pathogenesis of the disease remains to be elucidated.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Liu</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Unlike primary open-angle glaucoma (POAG) or juvenile open-angle glaucoma (JOAG), juvenile glaucoma can be associated with goniodysgenesis, a maldevelopment of the iridocorneal angle of the eye [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. If intraocular pressure (IOP) becomes elevated after the age of three (late congenital glaucoma), the patients may not present symptoms such as buphthalmos, lacrimation, photophobia, and blepharospasm.</p><p>Genetic factors play a major role in the pathogenesis of glaucoma, but the molecular basis still remains unknown. To date, about 23 loci have been linked to different types of glaucoma, and four genes, myocilin (<italic>MYOC</italic>), optineurin (<italic>OPTN</italic>), cytochrome P450 1B1 (<italic>CYP1B1</italic>), and WD repeat domain 36 (<italic>WDR36</italic>), have been identified as glaucoma causing genes [<xref ref-type="bibr" rid="r3">3</xref>-<xref ref-type="bibr" rid="r6">6</xref>]. MYOC is a secreted glycoprotein normally expressed in several ocular and non-ocular tissues. To date, more than 70 mutations have been detected in <italic>MYOC</italic> in different population groups, contributing to approximately 3% of familial autosomal dominant adult-onset open-angle glaucoma and a greater proportion of JOAG. Most of the mutations were located in exon 3 where the olfactomedin-like domain is located [<xref ref-type="bibr" rid="r7">7</xref>]. Recently, mutations in <italic>MYOC</italic> have been linked to primary congenital glaucoma in India and China [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r10">10</xref>].</p><p><italic>CYP1B1</italic> has been shown to cause primary congenital glaucoma (PCG), JOAG, and POAG [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r11">11</xref>-<xref ref-type="bibr" rid="r13">13</xref>]. It is thought that <italic>CYP1B1</italic> participates in the development of trabecular meshwork (TM) of the eye [<xref ref-type="bibr" rid="r12">12</xref>]. <italic>CYP1B1</italic> consists of three exons of which only exons 2 and 3 encode the protein. So far, certain sequence variances in <italic>CYP1B1</italic> such as g.3947 C&#x0003e;G (R48G) in exon 2 and 372&#x02212;12 C&#x0003e;T in intron 1 have been identified as single nucleotide polymorphisms (SNPs) based on sequence analyses [<xref ref-type="bibr" rid="r14">14</xref>].</p><p>In this study, alterations in <italic>MYOC</italic> were analyzed, and a known mutation, which was segregated with the disorder within the family and appeared to be the disease-causing gene, was found. However, this still cannot explain the goniodysgenesis predominantly seen in patients of this family. We therefore investigated <italic>CYP1B1</italic>, a gene known to be related to the development of the iridocorneal angle [<xref ref-type="bibr" rid="r11">11</xref>]. Mutations in both <italic>MYOC</italic> and <italic>CYP1B1</italic> have been found in the juvenile or early-onset glaucoma pedigree. These mutations are different from what we first reported in the study of a juvenile glaucoma pedigree with goniodysgenesis, although these mutations were previously reported in POAG and PCG.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Family recruitment and clinical examination</title><p>A three-generation family with juvenile glaucoma with goniodysgenesis was recruited from the clinic of the Department of Ophthalmology at West China Hospital (Sichuan University, Chengdu, P. R. China). The study was approved by the medical ethics committee of the West China Hospital of Sichuan University. This study adhered to the tenets of the Declaration of Helsinki. All subjects were clinically evaluated by glaucoma specialists and diagnosed with juvenile glaucoma with goniodysgenesis.</p><p>Juvenile glaucoma with goniodysgenesis belongs to developmental glaucoma, which was defined as meeting all of the following criteria: goniodysgenesis with secondary causes (e.g., trauma, uveitis, or steroid-induced glaucoma) excluded; open anterior chamber angle; IOP greater than 21&#x000a0;mmHg in both eyes; and characteristic glaucomatous optic disc damage and/or visual field loss. The pedigree structure of the Chinese family with summaries of the variations in <italic>MYOC</italic> and <italic>CYP1B1</italic> is described in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Pedigree of the Chinese glaucoma family. The variations of <italic>MYOC</italic> and <italic>CYP1B1</italic> genes were summarized in this figure of the Chinese family segregating juvenile glaucoma with goniodysgenesis. The <italic>MYOC</italic> heterozygous mutation, C&#x0003e;T (P370L) in exon 3 was identified in all six patients but not in asymptomatic family members. Two<italic> CYP1B1</italic> SNPs, C&#x0003e;G (R48G) in exon 2 and C&#x0003e;T in intron 1, were identified in all six patients and but not in asymptomatic family members except the proband&#x02019;s paternal grandmother. Abbreviations: MY, <italic>MYOC</italic>; CY, <italic>CYP1B1</italic>. Arrow indicates the proband. (III:1).</p></caption><graphic xlink:href="mv-v15-1530-f1"/></fig></sec><sec><title>DNA extraction</title><p>Genomic DNA was extracted from 200&#x000a0;&#x003bc;l whole blood using a Qiamp Blood Kit (Qiagen, Hilden, Germany). All the procedures were performed according to the manufacturer&#x02019;s protocol. DNA integrity was evaluated by 1% agarose gel electrophoresis.</p></sec><sec><title>PCR amplification</title><p>Intronic primers flanking the exons (<xref ref-type="table" rid="t1">Table 1</xref>) were designed based on gene sequences of <italic>MYOC</italic> (GenBank <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/2104788">AF001620</ext-link>) and <italic>CYP1B1</italic> (GenBank <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/1663555">U56438</ext-link>) and synthesized by Invitrogen (Carlsbad, CA). DNA fragments were amplified by polymerase chain reaction (PCR) using a MyCycler thermocycler (Bio-Rad, Hercules, CA). The 30 &#x003bc;l PCR reaction mixture included 30 ng DNA, 1&#x000d7; PCR buffer, 2.5&#x000a0;mM MgCl<sub>2</sub>, 0.3&#x000a0;mM of each of dNTPs, 1.5 U Pfu DNA polymerase, and 1.0&#x000a0;&#x003bc;M each of the forward and reverse primers. All reagents used in this procedure were purchased from MBI (MBI Fermentas, Vilnius, Lithuania). The reactions were incubated in a 96 well plate at 95&#x000a0;&#x000b0;C for 2 min followed by 30 cycles at 94&#x000a0;&#x000b0;C for 10 s, 54&#x000a0;&#x000b0;C&#x02013;56&#x000a0;&#x000b0;C for 30s, and 72 &#x000b0;C for 1&#x02013;2 min and then a final extension at 72&#x000a0;&#x000b0;C for 5 min.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primers used in PCR for amplification of <italic>MYOC</italic> and <italic>CYP1B1</italic>.</title></caption><table frame="hsides" rules="groups"><col width="117" span="1"/><col width="208" span="1"/><col width="116" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Exons</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Primer sequence (forward/reverse)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Product size (bp)</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>MYOC</italic> 1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-TCACCAAGCCTCTGCAATG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">654<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-TGAACTCAGAGTCCCCCCAC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>MYOC</italic> 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-GCACCTGCCACCACATCC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">657<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-ACACATCTCTCATCTTGCCC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>MYOC</italic> 3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-GCTGTCACATCTACTGGCTC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">927<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-ATCTCCTTCTGCCATTGCCT-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CYP1B1</italic> 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-CATTTCTCCAGAGAGTCAGC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1260<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-GCTTGCAAACTCAGCATATTC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CYP1B1</italic> 3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-ACCCAATGGAAAAGTCAGCC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">927<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;-GCTTGCCTCTTGCTTCTTATT-3&#x02032;</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>The first column shows the sequenced exons of <italic>MYOC</italic> and <italic>CYP1B1</italic>; the second column shows the primer sequences, both forward and reverse ones, used to amplify the corresponding exons indicated in the first column; the third column shows the expected size of the PCR products.</p></table-wrap-foot></table-wrap></sec><sec><title>&#x0feff;Sequencing and data analysis</title><p>PCR products were directly sequenced using an ABI 377XL automated DNA sequencer (Applied Biosystems, Foster City, CA). Sequence data were compared pair-wise with the published <italic>MYOC</italic> and <italic>CYP1B1</italic> sequences.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>The proband</title><p>The proband (III:1) was diagnosed with glaucoma (late stage, both eyes) at the age of 16 years. A cup-disc ratio of 0.90&#x02013;1.0, elevated IOP (42&#x000a0;mmHg in the right eye and 34&#x000a0;mmHg in the left eye), and goniodysgenesis as described below were observed. No other ocular abnormalities or systemic disorders were found. Trabeculectomy was performed for both eyes. Three years after surgery, a cup-disc ratio of 0.95&#x02013;1.0, open grade III (Shaffer) angles, and late-stage glaucomatous visual field loss were noticed in both eyes (<xref ref-type="fig" rid="f2">Figure 2</xref>). His developmental angle anomaly was characterized by the absence of the angle recess in some area and the presence of iris tissue inserted either flat or concave shaped directly into the trabecular meshwork all over the iridocorneal angle.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Clinical manifestations of the proband. <bold>A</bold> and <bold>B</bold> showed the maldevelopment of the anterior chamber angle. <bold>C</bold> and <bold>D</bold> showed glaucomatous optic disc atrophy and visual field defects, respectively.</p></caption><graphic xlink:href="mv-v15-1530-f2"/></fig></sec><sec><title>Other affected family members</title><p>The IOP of the affected members including the proband in this family varied between 25 mmHg and 55&#x000a0;mmHg, depending on different treatment situations (no treatment, topical antiglaucoma medications, and/or surgeries) for each individual. The proband&#x02019;s father (II:1) was diagnosed with glaucoma at 24 years of age. Six years after the diagnosis, he became blind in both eyes. The father&#x02019;s two younger sisters (II:3 and II:4) were affected, but his younger brother (II:6) was normal. The proband&#x02019;s mother did not have any ocular disorders, and she did not recall any glaucoma cases among her lineage or relatives. The proband&#x02019;s paternal grandfather (I:1) and grandmother (I:2) had a consanguineous marriage. The grandfather (I:1) has had glaucoma since he was young, and the grandmother (I:2) never had glaucoma or other noticeable ocular disorders.</p><p>Goniodysgenesis as described in the proband was noticed in four of his relatives with relatively transparent corneas. None of the affected individuals showed an enlarged cornea, excessive tearing, or photophobia. <xref ref-type="table" rid="t2">Table 2</xref> is a summary of the major clinical findings and the variations in <italic>MYOC</italic> and <italic>CYP1B1</italic> of the affected members in this family.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Clinical findings in glaucoma patients in this the family.</title></caption><table frame="hsides" rules="groups"><col width="54" span="1"/><col width="52" span="1"/><col width="60" span="1"/><col width="56" span="1"/><col width="59" span="1"/><col width="116" span="1"/><col width="58" span="1"/><col width="55" span="1"/><col width="55" span="1"/><thead><tr><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Subject</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Sex/Age (years)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Highest IOP (mmHg) Observed (OD/OS)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Cup-disc ratio (OD/OS)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Visual acuity (OD/OS)</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Trabeculodysgenesis</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Mutation</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>SNPs</bold><hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold><italic>MYOC</italic> P370L</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>CYP1B1</italic> R48G</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>CYP1B1</italic> C&#x0003e;T</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">III:1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">M/26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28/23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.0/0.95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1/0.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">yes/yes<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">III:2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">M/22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25/44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.0/1.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NLP/NLP<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">yes/yes<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">II:1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">M/41<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52/NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.0/inv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NLP/NLP<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">yes/inv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">hom<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">hom<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">II:3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F/44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA/50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">inv/inv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NLP/NLP<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">inv/inv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">hom<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">hom<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">II:4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F/39<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53/57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">inv/inv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NLP/NLP<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">yes/yes<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">het<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">I:1</td><td valign="top" align="center" rowspan="1" colspan="1">M/71</td><td valign="top" align="center" rowspan="1" colspan="1">34/30</td><td valign="top" align="center" rowspan="1" colspan="1">1.0/1.0</td><td valign="top" align="center" rowspan="1" colspan="1">NLP/ FC</td><td valign="top" align="center" rowspan="1" colspan="1">yes/yes</td><td valign="top" align="center" rowspan="1" colspan="1">het</td><td valign="top" align="center" rowspan="1" colspan="1">het</td><td valign="top" align="center" rowspan="1" colspan="1">het</td></tr></tbody></table><table-wrap-foot><p>The clinical information of the glaucoma patients in this pedigree were shown in this table, including gender, age, highest IOP, cup-disc ratio, visual acuity, trabeculodisgenesis and sequence variations found in <italic>MYOC</italic> and <italic>CYP1B1</italic>. In the table, abbreviations are: M, male; F, female; OD, right eye; OS, left eye; IOP, intraocular pressure; NLP, no light perception; FC, Figure counting; inv, invisible due to cornea opacification and/or cataract; het, heterozygous; hom, homozygous.</p></table-wrap-foot></table-wrap></sec><sec><title>Asymptomatic family members</title><p>The proband&#x02019;s paternal grandmother (I:2) was 65 years old, and her visual acuity was 20/25 with corrections. The visual acuities of the proband&#x02019;s paternal uncle (II:6) who was the only unaffected person in the second generation and of the other two unaffected individuals (III:3 and III:4) were 20/20. The IOP, anterior chamber angle, and the cup-disc ratio of all asymptomatic members were in normal ranges.</p></sec><sec><title>Sequencing results</title><p>The mutations that cosegregated with the disorder within the family are summarized in <xref ref-type="fig" rid="f1">Figure 1</xref> and <xref ref-type="table" rid="t2">Table 2</xref>.</p><sec><title>MYOC</title><p>Sequence analysis of <italic>MYOC</italic> revealed a heterozygous mutation, C&#x0003e;T <bold>(</bold>P370L), in exon 3 in all patients but not in any of the asymptomatic members of the family. The P370L <italic>MYOC</italic> mutation cosegregated with the disorder within the family. And one SNP of <italic>MYOC</italic> was identified in intron 2 (A&#x0003e;G; <xref ref-type="fig" rid="f3">Figure 3</xref>).</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p><italic>MYOC</italic> mutation and variation in the glaucoma family. <bold>A</bold>: Heterozygous C&#x0003e;T <bold>(</bold>P370L) mutation of <italic>MYOC</italic> is shown. <bold>B</bold>: A&#x0003e;G variation of <italic>MYOC</italic> is shown. Arrows indicate the sequence difference, and the one in red indicates the wild type sequence.</p></caption><graphic xlink:href="mv-v15-1530-f3"/></fig></sec><sec><title>CYP1B1 </title><p>Two <italic>CYP1B1</italic> SNPs, C&#x0003e;G (R48G) in exon 2 and C&#x0003e;T in intron 1, were identified. These two SNPs occurred in all six patients afflicted with glaucoma (four were heterozygous and two were homozygous) and were not found in any of the asymptomatic family members except the proband&#x02019;s grandmother (<xref ref-type="fig" rid="f4">Figure 4</xref>). Two SNPs were identified, G&#x0003e;C (V432L) and T&#x0003e;C (D449D) both in exon 3 of <italic>CYP1B1</italic> (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Two <italic>CYP1B1</italic> SNPs in the glaucoma family. <bold>A</bold>: C&#x0003e;G variation in exon 2 of <italic>CYP1B1</italic>. The codon CGG in exon 2 was replaced by GGG, resulting in a change of amino acid from arginine to glycine (R48G). <bold>B</bold>: C&#x0003e;T variation in intron 1 of <italic>CYP1B1</italic>. These two SNPs occurred in all six patients afflicted with glaucoma, and were not found in asymptomatic family members except the proband&#x02019;s paternal grandmother. Arrows indicate the sequence difference, and the one in red indicates the wild type sequence.</p></caption><graphic xlink:href="mv-v15-1530-f4"/></fig><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>Two <italic>CYP1B1</italic> variations in the glaucoma family. <bold>A</bold>: G&#x0003e;C (V432L) variation in exon 3 of <italic>CYP1B1</italic>. <bold>B</bold>: T&#x0003e;C (D449D) variation in exon 3 of <italic>CYP1B1</italic>. Arrows indicate the sequence difference.</p></caption><graphic xlink:href="mv-v15-1530-f5"/></fig></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The terms congenital, developmental, infantile, and juvenile glaucoma appear to be overlapping and confusing. Because of a variation in the severity of angle abnormalities, glaucoma may appear early or late in life. Therefore, it may not be appropriate to decide the classification or the mode of inheritance of the glaucoma based on the patient's age at the onset of the symptoms when angle abnormality is the common etiologic factor [<xref ref-type="bibr" rid="r1">1</xref>]. A child with primary glaucoma but without angle abnormalities should be diagnosed as JOAG. Any childhood glaucoma caused by maldevelopment of the iridocorneal angle is considered primary congenital glaucoma, which is usually characterized by buphthalmos, lacrimation, photophobia, and blepharospasm. For the affected patients in this pedigree, these symptoms were not noticed by either themselves or by ophthalmologists at the first visit. No evidence is available for the exact ages when they had glaucoma, but the onset of glaucoma is likely much earlier than the time they noticed having eye problems. For example, one of the patients (III:2) mentioned that he had &#x0201c;high myopia that got worse very fast&#x0201d; when he was in primary school. Cornea damage occurred in some of the patients probably due to long-term uncontrolled high IOP. A gonioscopic examination was performed for those eyes with relatively transparent cornea, and all of them showed developmental iridocorneal angle anomaly.</p><p>More than 70 mutations have been identified in <italic>MYOC</italic> of POAG patients from India, England, France, North America, Japan, and Germany, indicating that different <italic>MYOC</italic> mutations may contribute to the pathogenesis of POAG in populations of different ethnicity [<xref ref-type="bibr" rid="r15">15</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. <italic>MYOC</italic> mutations were also found in a few cases of sporadic PCG [<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r23">23</xref>]. Zhou et al. [<xref ref-type="bibr" rid="r24">24</xref>] reported the homozygous mutation in intron 2 of <italic>MYOC</italic> in one family with both PCG and POAG in China. In that pedigree, one was diagnosed as a PCG patient who developed symptoms of epiphora, photophobia, edematous, enlarged cornea, and increased ocular axial length while the anterior chamber angle was found open and &#x0201c;normal&#x0201d;, and no maldevelopment of the iridocorneal angle was noticed [<xref ref-type="bibr" rid="r24">24</xref>]. In our study, <italic>MYOC</italic> was screened for mutations in the pedigree with juvenile glaucoma with goniodysgenesis. P370L as a heterozygous mutation was identified in <italic>MYOC</italic> in the affected members but not in the normal individuals, and the mutation cosegregated with the disorder within the pedigree, suggesting that <italic>MYOC</italic> may be the glaucoma-causing gene in this family.</p><p>However, the <italic>MYOC</italic> mutation does not support a role of this gene in the maldevelopment of the iridocorneal angle. Therefore, another candidate gene, <italic>CYP1B1</italic>, was screened. Previous studies have identified <italic>CYP1B1</italic> as a causative gene in PCG and occasionally as a causative gene in POAG as well as several anterior segment dysgenesis disorders [<xref ref-type="bibr" rid="r25">25</xref>]. Furthermore, <italic>CYP1B1</italic>-deficient mice exhibit abnormalities in their ocular drainage structure and trabecular meshwork (TM), which are similar to those reported in human PCG patients [<xref ref-type="bibr" rid="r26">26</xref>]. It was speculated that the CYP1B1 protein might be involved in the generation of a regulatory molecule that controls the expression of genes involved in the development of the anterior chamber angle [<xref ref-type="bibr" rid="r25">25</xref>]. In this pedigree, the R48G variation in exon 2 and C&#x0003e;T variation in intron 1 of <italic>CYP1B1</italic> were found in all six patients and not in any of the asymptomatic family members except the proband&#x02019;s grandmother. We tried to compare the phenotypes between the two patients homozygous for the <italic>CYP1B1</italic> variation and the others heterozygous for these variations. The former did show a more severe and complicated phenotype such as cataract. However, both of them received less antiglaucoma treatments, which may explain the severity of the disorder.</p><p>Studies by Hollander et al. [<xref ref-type="bibr" rid="r27">27</xref>] have indicated that multiple <italic>CYP1B1</italic> variances in which the R48G was not included may be associated with severe or moderate goniodysgenesis in congenital glaucoma. In our pedigree study, individuals carrying both the <italic>MYOC</italic> mutation and <italic>CYP1B1</italic> variation were affected with juvenile glaucoma with goniodysgenesis. However, it is still unlikely that the combination of <italic>MYOC</italic> and <italic>CYP1B1</italic> variations correlate with an earlier manifestation of the disease. The <italic>CYP1B1</italic> variation described in this study, C&#x0003e;G (R48G) in exon 2, has not been reported to be associated with goniodysgenesis, and it was identified as an SNP previously. Stoilov IR et al. [<xref ref-type="bibr" rid="r14">14</xref>] have reported that the R48G variation frequency was 0.29 in normal populations in the UK and Turkey. It was also reported that R48G variation frequency was 0.295 and 0.205 in patients with primary congenital glaucoma and normal populations, respectively, in Brazil, and the frequency variation was 0.435 and 0.39 in patients of JOAG and normal populations, respectively, in India [<xref ref-type="bibr" rid="r28">28</xref>,<xref ref-type="bibr" rid="r29">29</xref>]. Therefore, this variance identified in this pedigree may just have coincidentally occurred in six patients. This is supported by the fact that this variance was also found in the proband&#x02019;s grandmother who was asymptomatic.</p><p>In conclusion, the P370L mutation of <italic>MYOC</italic> in this pedigree appears to be the cause of the disease. However, it remains unclear the gene defect underlying goniodysgenesis of the six patients with both a <italic>MYOC</italic> mutation and <italic>CYP1B1</italic> variance. Previous studies indicated that <italic>CYP1B1</italic> may act as a modifier of <italic>MYOC</italic> expression and that the two genes may interact via a common pathway [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r30">30</xref>]. Obviously, further studies are needed to elucidate the possible role of <italic>CYP1B1</italic> variations such as R48G in juvenile glaucoma with goniodysgenesis.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by grants from the National Natural Science foundation of China (NNSF 30772379, 30600690, 30872830).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jerndal</surname><given-names>T</given-names></name></person-group><article-title>Congenital glaucoma due to dominant goniodysgenesis. A new concept of the heredity of glaucoma.</article-title><source>Am J Hum Genet</source><year>1983</year><volume>35</volume><fpage>645</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">6881141</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mears</surname><given-names>AJ</given-names></name><name><surname>Mirzayans</surname><given-names>F</given-names></name><name><surname>Gould</surname><given-names>DB</given-names></name><name><surname>Pearce</surname><given-names>WG</given-names></name><name><surname>Walter</surname><given-names>MA</given-names></name></person-group><article-title>Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25.</article-title><source>Am J Hum Genet</source><year>1996</year><volume>59</volume><fpage>1321</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8940278</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>EM</given-names></name><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Nguyen</surname><given-names>TD</given-names></name><name><surname>Polansky</surname><given-names>JR</given-names></name><name><surname>Sunden</surname><given-names>SL</given-names></name><name><surname>Nishimura</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>AF</given-names></name><name><surname>Nystuen</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>BE</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Kalenak</surname><given-names>JW</given-names></name><name><surname>Craven</surname><given-names>ER</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name></person-group><article-title>Identification of a gene that causes primary open angle glaucoma.</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>668</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">9005853</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>T</given-names></name><name><surname>Child</surname><given-names>A</given-names></name><name><surname>Hitchings</surname><given-names>R</given-names></name><name><surname>Brice</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>L</given-names></name><name><surname>Coca-Prados</surname><given-names>M</given-names></name><name><surname>H&#x000e9;on</surname><given-names>E</given-names></name><name><surname>Krupin</surname><given-names>T</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Kreutzer</surname><given-names>D</given-names></name><name><surname>Crick</surname><given-names>RP</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Adult-onset primary open-angle glaucoma caused by mutations in optineurin.</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>1077</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11834836</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoilov</surname><given-names>I</given-names></name><name><surname>Akarsu</surname><given-names>AN</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Identification of three different truncating mutations in cytochrome P4501B1 (<italic>CYP1B1</italic>) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>641</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9097971</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monemi</surname><given-names>S</given-names></name><name><surname>Spaeth</surname><given-names>G</given-names></name><name><surname>DaSilva</surname><given-names>A</given-names></name><name><surname>Popinchalk</surname><given-names>S</given-names></name><name><surname>Ilitchev</surname><given-names>E</given-names></name><name><surname>Liebmann</surname><given-names>J</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>H&#x000e9;on</surname><given-names>E</given-names></name><name><surname>Crick</surname><given-names>RP</given-names></name><name><surname>Child</surname><given-names>A</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>725</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15677485</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozsa</surname><given-names>FW</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Lichter</surname><given-names>PR</given-names></name><name><surname>Johnson</surname><given-names>AT</given-names></name><name><surname>Othman</surname><given-names>MI</given-names></name><name><surname>Scott</surname><given-names>K</given-names></name><name><surname>Downs</surname><given-names>CA</given-names></name><name><surname>Nguyen</surname><given-names>TD</given-names></name><name><surname>Polansky</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>JE</given-names></name></person-group><article-title>GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein.</article-title><source>Mol Vis</source><year>1998</year><volume>4</volume><fpage>20</fpage><pub-id pub-id-type="pmid">9772276</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>K</given-names></name><name><surname>Komatireddy</surname><given-names>S</given-names></name><name><surname>Acharya</surname><given-names>M</given-names></name><name><surname>Devi</surname><given-names>KR</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Hasnain</surname><given-names>SE</given-names></name><name><surname>Chandrasekhar</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name></person-group><article-title>Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotype in India.</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>111</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15723004</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>BJ</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Wang</surname><given-names>DY</given-names></name><name><surname>Gobeil</surname><given-names>S</given-names></name><name><surname>Raymond</surname><given-names>V</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name></person-group><article-title>Novel myocilin mutation in a Chinese family with juvenile-onset open-angle glaucoma.</article-title><source>Arch Ophthalmol</source><year>2006</year><volume>124</volume><fpage>102</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16401791</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Zhuo</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Ming</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>W</given-names></name></person-group><article-title>Genemutation in patients with primary open-angle glaucoma in a pedigree in China.</article-title><source>Chin Med J (Engl)</source><year>2000</year><volume>113</volume><fpage>195</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11775243</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Billingsley</surname><given-names>G</given-names></name><name><surname>Buys</surname><given-names>Y</given-names></name><name><surname>Levin</surname><given-names>AV</given-names></name><name><surname>Priston</surname><given-names>M</given-names></name><name><surname>Trope</surname><given-names>G</given-names></name><name><surname>Williams-Lyn</surname><given-names>D</given-names></name><name><surname>H&#x000e9;on</surname><given-names>E</given-names></name></person-group><article-title>Digenic inheritance of early-onset glaucoma: <italic>CYP1B1</italic>, a potential modifier gene.</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>448</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11774072</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melki</surname><given-names>R</given-names></name><name><surname>Colomb</surname><given-names>E</given-names></name><name><surname>Lefort</surname><given-names>N</given-names></name><name><surname>Br&#x000e9;zin</surname><given-names>AP</given-names></name><name><surname>Garchon</surname><given-names>HJ</given-names></name></person-group><article-title><italic>CYP1B1</italic> mutations in French patients with early-onset primary open-angle glaucoma.</article-title><source>J Med Genet</source><year>2004</year><volume>41</volume><fpage>647</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15342693</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bejjani</surname><given-names>BA</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Tomey</surname><given-names>KF</given-names></name><name><surname>Anderson</surname><given-names>KL</given-names></name><name><surname>Dueker</surname><given-names>DK</given-names></name><name><surname>Jabak</surname><given-names>M</given-names></name><name><surname>Astle</surname><given-names>WF</given-names></name><name><surname>Otterud</surname><given-names>B</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name></person-group><article-title>Mutations in <italic>CYP1B1</italic>, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia.</article-title><source>Am J Hum Genet</source><year>1998</year><volume>62</volume><fpage>325</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9463332</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoilov</surname><given-names>I</given-names></name><name><surname>Akarsu</surname><given-names>AN</given-names></name><name><surname>Alozie</surname><given-names>I</given-names></name><name><surname>Child</surname><given-names>A</given-names></name><name><surname>Barsoum-Homsy</surname><given-names>M</given-names></name><name><surname>Turacli</surname><given-names>ME</given-names></name><name><surname>Or</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Ozdemir</surname><given-names>N</given-names></name><name><surname>Brice</surname><given-names>G</given-names></name><name><surname>Aktan</surname><given-names>SG</given-names></name><name><surname>Chevrette</surname><given-names>L</given-names></name><name><surname>Coca-Prados</surname><given-names>M</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.</article-title><source>Am J Hum Genet</source><year>1998</year><volume>62</volume><fpage>573</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">9497261</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>H&#x000e9;on</surname><given-names>E</given-names></name><name><surname>Liebmann</surname><given-names>JM</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name><name><surname>Rait</surname><given-names>J</given-names></name><name><surname>Kawase</surname><given-names>K</given-names></name><name><surname>Hoh</surname><given-names>ST</given-names></name><name><surname>Buys</surname><given-names>YM</given-names></name><name><surname>Dickinson</surname><given-names>J</given-names></name><name><surname>Hockey</surname><given-names>RR</given-names></name><name><surname>Williams-Lyn</surname><given-names>D</given-names></name><name><surname>Trope</surname><given-names>G</given-names></name><name><surname>Kitazawa</surname><given-names>Y</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.</article-title><source>Hum Mol Genet</source><year>1999</year><volume>8</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">10196380</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>MF</given-names></name><name><surname>Belmouden</surname><given-names>A</given-names></name><name><surname>Binisti</surname><given-names>P</given-names></name><name><surname>Br&#x000e9;zin</surname><given-names>AP</given-names></name><name><surname>Valtot</surname><given-names>F</given-names></name><name><surname>B&#x000e9;chetoille</surname><given-names>A</given-names></name><name><surname>Dascotte</surname><given-names>JC</given-names></name><name><surname>Copin</surname><given-names>B</given-names></name><name><surname>Gomez</surname><given-names>L</given-names></name><name><surname>Chaventr&#x000e9;</surname><given-names>A</given-names></name><name><surname>Bach</surname><given-names>JF</given-names></name><name><surname>Garchon</surname><given-names>HJ</given-names></name></person-group><article-title>Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of <italic>TIGR</italic> in familial open-angle glaucoma.</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>2091</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9328473</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Shirato</surname><given-names>S</given-names></name><name><surname>Taniguchi</surname><given-names>F</given-names></name><name><surname>Ohara</surname><given-names>K</given-names></name><name><surname>Nishimaki</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>S</given-names></name></person-group><article-title>Mutations in the <italic>TIGR</italic> gene in familial primary open-angle glaucoma in Japan.</article-title><source>Am J Hum Genet</source><year>1997</year><volume>61</volume><fpage>1202</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9345106</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoilova</surname><given-names>D</given-names></name><name><surname>Child</surname><given-names>A</given-names></name><name><surname>Brice</surname><given-names>G</given-names></name><name><surname>Desai</surname><given-names>T</given-names></name><name><surname>Barsoum-Homsy</surname><given-names>M</given-names></name><name><surname>Ozdemir</surname><given-names>N</given-names></name><name><surname>Chevrette</surname><given-names>L</given-names></name><name><surname>Adam</surname><given-names>MF</given-names></name><name><surname>Garchon</surname><given-names>HJ</given-names></name><name><surname>Pitts Crick</surname><given-names>R</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Novel <italic>TIGR</italic>/<italic>MYOC</italic> mutations in families with juvenile onset primary open angle glaucoma.</article-title><source>J Med Genet</source><year>1998</year><volume>35</volume><fpage>989</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">9863594</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faucher</surname><given-names>M</given-names></name><name><surname>Anctil</surname><given-names>JL</given-names></name><name><surname>Rodrigue</surname><given-names>MA</given-names></name><name><surname>Duchesne</surname><given-names>A</given-names></name><name><surname>Bergeron</surname><given-names>D</given-names></name><name><surname>Blondeau</surname><given-names>P</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>G</given-names></name><name><surname>Dubois</surname><given-names>S</given-names></name><name><surname>Bergeron</surname><given-names>J</given-names></name><name><surname>Arseneault</surname><given-names>R</given-names></name><name><surname>Morissette</surname><given-names>J</given-names></name><name><surname>Raymond</surname><given-names>V</given-names></name><collab>Qu&#x000e9;bec Glaucoma Network.</collab></person-group><article-title>Founder <italic>TIGR</italic>/myocilin mutations for glaucoma in the Quebec population.</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>2077</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12189160</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennan</surname><given-names>AM</given-names></name><name><surname>Mansergh</surname><given-names>FC</given-names></name><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Clark</surname><given-names>T</given-names></name><name><surname>Ayuso</surname><given-names>C</given-names></name><name><surname>Kenna</surname><given-names>PF</given-names></name><name><surname>Humphries</surname><given-names>P</given-names></name><name><surname>Farrar</surname><given-names>GJ</given-names></name></person-group><article-title>A novel Asp380Ala mutation in the GLC1A/myocilin gene in a family with juvenile onset primary open angle glaucoma.</article-title><source>J Med Genet</source><year>1998</year><volume>35</volume><fpage>957</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9832047</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>F</given-names></name><name><surname>Yamagata</surname><given-names>Z</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Ishijima</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Iijima</surname><given-names>H</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name></person-group><article-title>A sequence change (Arg158Gln) in the leucine zipper-like motif region of the MYOC/TIGR protein.</article-title><source>J Hum Genet</source><year>2001</year><volume>46</volume><fpage>85</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11281418</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansergh</surname><given-names>FC</given-names></name><name><surname>Kenna</surname><given-names>PF</given-names></name><name><surname>Ayuso</surname><given-names>C</given-names></name><name><surname>Kiang</surname><given-names>AS</given-names></name><name><surname>Humphries</surname><given-names>P</given-names></name><name><surname>Farrar</surname><given-names>GJ</given-names></name></person-group><article-title>Novel mutations in the <italic>TIGR</italic> gene in early and late onset open angle glaucoma.</article-title><source>Hum Mutat</source><year>1998</year><volume>11</volume><fpage>244</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">9521427</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>K</given-names></name><name><surname>Reddy</surname><given-names>AB</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Hasnain</surname><given-names>SE</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Balasubramanian</surname><given-names>D</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name></person-group><article-title>Myocilin gene implicated in primary congenital glaucoma.</article-title><source>Clin Genet</source><year>2005</year><volume>67</volume><fpage>335</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15733270</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuo</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>YT</given-names></name><name><surname>Huang</surname><given-names>YL</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name></person-group><article-title>Analysis of <italic>MYOC</italic> gene mutation in a Chinese glaucoma family with primary open-angle glaucoma and primary congenital glaucoma.</article-title><source>Chin Med J (Engl)</source><year>2006</year><volume>119</volume><fpage>1210</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16863615</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasiliou</surname><given-names>V</given-names></name><name><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><article-title>Role of <italic>CYP1B1</italic> in glaucoma.</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2008</year><volume>48</volume><fpage>333</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">17914928</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>D</given-names></name><name><surname>Jansson</surname><given-names>I</given-names></name><name><surname>Rezaul</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>DK</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name><name><surname>Schenkman</surname><given-names>JB</given-names></name></person-group><article-title>Cyp1b1 protein in the mouse eye during development: an immunohistochemical study.</article-title><source>Drug Metab Dispos</source><year>2007</year><volume>35</volume><fpage>987</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17325023</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>DA</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name><name><surname>Stoilov</surname><given-names>I</given-names></name><name><surname>Wood</surname><given-names>IS</given-names></name><name><surname>Fredrick</surname><given-names>DR</given-names></name><name><surname>Alvarado</surname><given-names>JA</given-names></name></person-group><article-title>Genotype and phenotype correlations in congenital glaucoma: CYP1B1 mutations, goniodysgenesis, and clinical characteristics.</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>142</volume><fpage>993</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">17157584</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoilov</surname><given-names>IR</given-names></name><name><surname>Costa</surname><given-names>VP</given-names></name><name><surname>Vasconcellos</surname><given-names>JP</given-names></name><name><surname>Melo</surname><given-names>MB</given-names></name><name><surname>Betinjane</surname><given-names>AJ</given-names></name><name><surname>Carani</surname><given-names>JC</given-names></name><name><surname>Oltrogge</surname><given-names>EV</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Molecular Genetics of Primary Congenital Glaucoma in Brazil.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>1820</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12036985</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>M</given-names></name><name><surname>Mookherjee</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Bandyopadhyay</surname><given-names>AK</given-names></name><name><surname>Daulat Thakur</surname><given-names>SK</given-names></name><name><surname>Bhaduri</surname><given-names>G</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name></person-group><article-title>Primary role of CYP1B1 in Indian juvenile-onset POAG patients.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">16688110</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagiyeva</surname><given-names>S</given-names></name><name><surname>Marfany</surname><given-names>G</given-names></name><name><surname>Gonzalez-Angulo</surname><given-names>O</given-names></name><name><surname>Gonzalez-Duarte</surname><given-names>R</given-names></name></person-group><article-title>Mutational screening of <italic>CYP1B1</italic> in Turkish PCG families and functional analyses of newly detected mutations.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>1458</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17893647</pub-id></mixed-citation></ref></ref-list></back></article>